#BEGIN_DRUGCARD DB02501

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H18N4O5

# Chemical_IUPAC_Name:
(2R)-5-carbamimidamido-2-(3-carboxypropanamido)pentanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
N~2~-Succinylarginine

# HET_ID:
SUG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H18N4O5/c11-10(12)13-5-1-2-6(9(18)19)14-7(15)3-4-8(16)17/h6H,1-5H2,(H,14,15)(H,16,17)(H,18,19)(H4,11,12,13)/t6-/m1/s1

# InChI_Key:
InChIKey=UMOXFSXIFQOWTD-ZCFIWIBFSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2501

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
274.2737

# Molecular_Weight_Mono:
274.127719706

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1YNI

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.5

# Predicted_LogS:
-2.8

# Predicted_Water_Solubility:
4.10e-01 g/l

# Primary_Accession_No:
DB02501

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
17754183

# PubChem_Substance_ID:
46507643

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02979

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC(=N)NCCC[C@@H](NC(=O)CCC(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:12 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U00096

# Drug_Target_1_GenBank_ID_Protein:
1788040

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
astB

# Drug_Target_1_Gene_Sequence:
>1344 bp
TTATCCATTGCCCCCTCCCTCGCGCTGGAACGGATAAACCGAACCGAGATTCAGTAATTG
GCTCAATACATCCAGTGCTTCCCGCCCTTCGCGCAGCAATTGCGGGTCGGCCAGATCGGC
AGCAGTAAGGCGATCGCGGTAGTAACGATCCACCCAGTCATTGAGCGCATTAAACAGCGT
ATCGTTCATCATCACCGCCGGATTCACCGCCCGGCGTTCTTCTTCTGTCAATACCACCCG
CAACCGCAGGCACGCCGGGCCGCCGCCATTCGCCATGCTTTCACGTAAATCAAAGACTTT
TAGTTCGCTAATCGGGTTGTCAGCGGCAAGGAGTTCATTGAGATAACCCCATACTCCGGC
GTGTTCCCGACACTCCTGAGGCAGCACCAACATCATGGAACCATCATCGCGGCTCAGCAG
TTGGCTGTTAAACAGATAGGTAGACACCGTATCAGACACGGAAACCTGAGTTGCCGGAAC
TTCTATCGCCATAAAACCATTGACCCGCGCACGCAGGTTTGCCAGTAACTGTGACTGGCG
AGCGAACGCCTGTTGGTGGCAAAACAGCACCTGGCGGTTACTCACGGCAATCACGTCATT
ATGAAAAACGCCCTGGTCGATAACGTCCGGGTTTTGCTGGGCGAAAATCACCTGTTGGGG
ATTCACCTGATTCAGCCTTGCCACCGCCTCGCTGGCTTCGCGAGTCTGTCGCGCCGGATA
ACGGGAAGGCCGGGTATCATTGCCTTCTTCTCGCCCGTAGACAAAAAGTTGCATACCCGG
TTCACCGTAATGACCGCCGAGACGATTGTGGTTTGCCGCCCCCTCATCACCGAGCAACGC
TACCTGTGGCAACGCCGAATGGACGCTAAATTTCTCTTCGTCGTTAAAAATCGCTTTTAA
CAGCGATTCAGTGACGGGCGCTTCCAGCGAACGGTGAAATTTATTGTTCAGGTTGGCAAC
GGTGAGATGCACTTTGCCATCCAGCGTATCGGCAGATGGCGCGATCGTTGCCGCATTGGC
TACCCACATTGGCGAAGCGGAACTGACGCTGGAAAGCCAGTGCGGTGCCTGGCGTGCAAC
TTTTTCCAGTACCTGCTCATCGCTACCACTGAATCCCAACTGACGCAGCACCGGAATAAA
CGGACGCTCGTGCGGCGGGATCACGGCCTGGGGGAATCCCGCATCGGCAAGGGCTTTCAT
TTTCAGTAAGCCCTGCTTCGCCGCCAGTCGCGGGTTAGACACCTGAAAACGGTGACGGGT
AGAGGCTTCATTACCAAACGACAGGCCCGCGTAATGATGCGTCAGCCCTACCAGCCCGTC
GAAATTGACTTCCCAGGCGTTCAT

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.
9696779	Schneider BL, Kiupakis AK, Reitzer LJ: Arginine catabolism and the arginine succinyltransferase pathway in Escherichia coli. J Bacteriol. 1998 Aug;180(16):4278-86.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3406

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
49299

# Drug_Target_1_Name:
N-succinylarginine dihydrolase

# Drug_Target_1_Number_of_Residues:
447

# Drug_Target_1_PDB_ID:
1YNH

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF04996	AstB

# Drug_Target_1_Protein_Sequence:
>N-succinylarginine dihydrolase
MNAWEVNFDGLVGLTHHYAGLSFGNEASTRHRFQVSNPRLAAKQGLLKMKALADAGFPQA
VIPPHERPFIPVLRQLGFSGSDEQVLEKVARQAPHWLSSVSSASPMWVANAATIAPSADT
LDGKVHLTVANLNNKFHRSLEAPVTESLLKAIFNDEEKFSVHSALPQVALLGDEGAANHN
RLGGHYGEPGMQLFVYGREEGNDTRPSRYPARQTREASEAVARLNQVNPQQVIFAQQNPD
VIDQGVFHNDVIAVSNRQVLFCHQQAFARQSQLLANLRARVNGFMAIEVPATQVSVSDTV
STYLFNSQLLSRDDGSMMLVLPQECREHAGVWGYLNELLAADNPISELKVFDLRESMANG
GGPACLRLRVVLTEEERRAVNPAVMMNDTLFNALNDWVDRYYRDRLTAADLADPQLLREG
REALDVLSQLLNLGSVYPFQREGGGNG

# Drug_Target_1_Reaction:
N2-succinyl-L-arginine + 2 H2O = N2-succinyl-L-ornithine + 2 NH3 + CO2

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the hydrolysis of 2-N-succinylarginine into 2- N-succinylornithine, ammonia and CO(2)

# Drug_Target_1_SwissProt_ID:
P76216

# Drug_Target_1_SwissProt_Name:
ASTB_ECOLI

# Drug_Target_1_Synonyms:
EC 3.5.3.23

# Drug_Target_1_Theoretical_pI:
6.06

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02501
